Physician profile
Sheldon S Greenberg
NPI 1013054121
$1,013.40
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $119 · 2020: $126 · 2021: $768.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $554.55 | 2021 | |
| Abbvie INC. | $165.20 | 2021 | |
| Sunovion Pharmaceuticals INC. | $129.08 | 2019-2021 | |
| Allergan, INC. | $75.93 | 2019-2020 | |
| Shire North American Group INC | $21.96 | 2019 | |
| Eisai INC. | $20.00 | 2021 | |
| Neos Therapeutics, LP | $17.50 | 2019 | |
| Bausch Health US, LLC | $15.19 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $13.99 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheldon Greenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.